The surface of every cell in our body is covered with dense sugar molecules that are key mediators of cell-cell, cell-ligand, and cell-pathogen interactions. Glycans are one of the major components of cells and play a key role in many physiological processes in the body (e.g., growth and development of the body and occurrence of diseases, etc.). Glycans on the cell surface are structurally rich and diverse. However, when the human body generates physiological activities, cell surface N-glycans produce changes in structure or expression, and thus cell surface N-glycans can be applied as an important marker for disease diagnosis. To deeply explore the physiological roles of glycans, it is necessary to apply Glycoengineering Techniques to determine their structures and complete sequences and to understand the information encoded in these glycan molecules and the mechanisms by which they facilitate protein-protein interactions.
Fig.1 Detection of cell surface glycans. (Nischan & Kohler, 2016)
A cell surface Lewis-type N-glycan is an N-linked glycan chain that contains one or more Lewis acid residues. Lewis-type N-glycans have important roles in biology, so their analysis and characterization are an important direction in glycomics.
We utilize a universal three-module technology for photo-controlled scarless selective glycan chain editing for chemical modification and editing of cell surface Lewis-type N-glycans at the protein-specific level. First, a Lewis-type N-glycan processing enzyme is specifically coupled to the protein to form a ligand-glycanase affix. Next, the protein of interest is targeted by ligand-receptor interactions while the glycanase is stationed on the protein to perform glycan editing events. Finally, chemical modification and editing of the N-glycan is accomplished.
In addition, at CD BioGlyco, we provide Lewis-type N-glycans structural analysis, sequence determination, and exploration of the physiological functions services by a Glycoengineering Platform.
Fig.2 Cell surface Lewis-type N-glycans glycoengineering services. (CD BioGlyco)
Paper Title: Enzymatic sequence analysis of N-glycans by exoglycosidase cleavage and mass spectrometry: detection of Lewis X structures.
Technology: Enzymatic and mass spectrometric sequencing of glycans
Journal: Methods in Molecular Biology
Published: 2019
Results: In this study, the authors describe enzyme sequence analysis applied to a mixture of acid glycoproteins released from α1-glycans. Possible Lewis X structures after exoglycosidase digestion were detected stepwise by MALDI-TOF mass spectrometry. In addition, other structural properties of the N-glycans were determined by using the respective specific extracellular glycosidases.
Fig.3 MALDI-TOF mass spectrometry of N-glycans released from an α1-acid glycoprotein and treated with different glycosidases. (Kannicht, et al., 2019)
CD BioGlyco has specialized in cell surface glycoengineering techniques and has developed a complete cell surface glycoengineering platform. We have services such as synthesis of Lewis-type N-glycans, structure and sequence analysis, and exploration of their expression. If you are interested in our services, please contact us for more details.
References